tiprankstipranks
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market

Design Therapeutics (DSGN) Income Statement

Compare
87 Followers

Design Therapeutics Income Statement

Last quarter (Q3 2024), Design Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Design Therapeutics's net income was $-13.04M. See Design Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 226.00$ 834.00
Gross Profit
$ -537.00K$ -466.00K$ -129.00K$ -4.77K$ -820.00
Operating Expenses
$ 78.19M$ 67.59M$ 35.83M$ 8.33M$ 1.91M
Depreciation and Amortization
$ 537.00K$ 466.00K$ 129.00K$ 5.00K$ 1.91M
EBITDA
$ -66.33M$ -62.84M$ -35.70M$ -8.32M$ -139.00K
Operating Income
$ -78.19M$ -67.59M$ -35.83M$ -8.33M$ -1.91M
Other Income/Expenses
$ 11.33M$ 4.29M$ 298.00K$ 50.00K$ -139.00K
Pretax Income
$ -66.86M$ -63.31M$ -35.53M$ -8.28M$ -2.05M
Net Income
$ -66.86M$ -58.62M$ -35.53M$ -8.28M$ -2.05M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.19$ -1.05$ -0.77$ -0.30$ -0.08
Diluted EPS
$ -1.19$ -1.05$ -0.77$ -0.30$ -0.08
Weighted Average Shares Outstanding
55.98M 55.71M 45.94M 27.19M 27.19M
Weighted Average Shares Outstanding (Diluted)
55.98M 55.71M 45.94M 27.19M 27.19M
Currency in USD

Design Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis